Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Technology Assessment: Criteria for Evaluating a Sustainable Energy Portfolio Read chapter Read first chapter

2016 | OriginalPaper | Chapter

9. National Technology Planning: A Case Study on the Biopharmaceutical Industry in China

Authors : Leong Chan, Tugrul U. Daim, Dundar F. Kocaoglu

Published in: Hierarchical Decision Modeling

Publisher: Springer International Publishing

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

In this research, a technology policy choice framework is developed to link prospective high-tech areas, technology development strategies, and various innovative resources. The research approach is to develop a Hierarchical Decision Model. Experts are invited from diverse sources to provide a balanced perspective representing different stakeholders. This research focuses on the fast developing Chinese biopharmaceutical industry as a case study. The results of this research have identified thirteen biotech areas, four strategies, and eight types of innovation resources to achieve industrial competitiveness in the biopharmaceutical industry. The research outcomes serve as guidelines in resource allocation and policy making for technology development.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter Strategic Planning: Model Development for Strategic Decision for Technology Selection in the Petrochemical Industry
next chapter National Technology Planning: A Case Study of Nanotechnology for Thailand’s Agriculture Industry
Literature
1.
Freeman, C. (1987). Technology policy and economic performance—Lessons from Japan. London: Pinter.
2.
Galama, T., & Hosek, J. (2008). U.S. competitiveness in science and technology. RAND.
3.
Fukuda, K., & Watanabe, C. (2008). Japanese and US perspectives on the National Innovation Ecosystem. Technology in Society, 30, 49–63.CrossRef
4.
Radosevic, S. (1999). International technology transfer and catch-up in economic development. Cheltenham: Edward Elgar.
5.
Zhouying, J. (2005). Globalization, technological competitiveness and the 'catch-up' challenge for developing countries: some lessons of experience. International Journal of Technology Management and Sustainable Development, 4, 35–46.CrossRef
6.
Bessant, J., & Tidd, J. (2007). Innovation and entrepreneurship. West Sussexs, England: John Wiley & Sons.
7.
Gerdsri, P. (2009). A systematic approach to developing national technology policy and strategy for emerging technologies. Portland State University
8.
Saaty, T. (1980). The analytical hierarchy process: Planning, priority setting, resource allocation. New York, NY: McGraw-Hill.
9.
Bieri, C. (2012). Global Pharma & Biotech M&A Report. IMAP.
10.
Sun, Q., Santoro, M. A., Meng, Q., Liu, C., & Eggleston, K. (2008). Pharmaceutical policy in China. Health Affairs, 27, 1042–1050.CrossRef
11.
Han, P. (2009). China's growing biomedical industry. Biologicals, 37, 169–172.CrossRef
12.
Daar, A. S., Thorsteinsdóttir, H., Martin, D. K., Smith, A. C., Nast, S., & Singer, P. A. (2006). Top Ten Biotechnologies for Improving Health in Developing Countries. United Nations Educational, Scientific and Cultural Organization (UNESCO).
13.
Arundel, A., Sawaya, D., & Valeanu I. (2009) Human Health Biotechnologies to 2015. Organization for Economic Co-Operation and Development (OECD).
14.
OECD. (2009). The Bioeconomy to 2030: Designing a Policy Agenda. Organization for Economic Co-Operation and Development.
15.
Chin, C. D. (2008). Biotechnology for global health: Solutions for the developing world. Consilience, 1, 1–12.
16.
White, S. (2000). Competition, capabilities, and the make, buy, or ally decisions of Chinese state-owned firms. The Academy of Management Journal, 43, 324–341.CrossRef
17.
Yang, J., & Shu, W. (2005). On the choice of technological innovation strategy of Chinese enterprises at present. China-USA Business Review, 4, 63–66.
18.
Lazonick, W. (2004). Indigenous innovation and economic development lessons from China’s leap into the information age. Industry and Innovation, 11, 273–297.CrossRef
19.
Jin, C. (2005). Towards Indigenous Innovation: Pathways for Chinese Firms. Workshop of Technology Innovation and Economic Development.
20.
Cheng, C. J., & Shiu, E. C. C. (2008). Re-innovation: The construct, measurement, and validation. Technovation, 28, 658–666.CrossRef
21.
Mukoyama, T. (2003). Innovation, imitation, and growth with cumulative technology. Journal of Monetary Economics, 50, 361–380.CrossRef
22.
Wang, X., Li, J. (2007). Innovation Network in Harvest. In International Conference on Technology Innovation, Risk Management, and Supply Chain Management. Beijing, pp. 420–424.
23.
Farhang, M. (1997). Managing technology transfer to China. International Marketing Review, 14, 92–106.CrossRef
24.
Guan, J. C., Mok, C. K., Yam, R. C. M., Chin, K. S., & Pun, K. F. (2006). Technology transfer and innovation performance: Evidence from Chinese firms. Technological Forecasting & Social Change, 73, 666–678.CrossRef
25.
Meyer, A. D. (2001). Technology transfer into China: preparing for a new era. European Management Journal, 19, 140–144.CrossRef
26.
Salicrup, L. A., & Fedorkova, L. (2006). Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries. Biotechnology Advances, 24, 69–79.CrossRef
27.
Jiang, Y., Wang, Y., & Yan, X. (2001). Chinese pharmaceutical companies: an emerging industry. Drug Discovery Today, 6, 610–612.CrossRef
28.
Wang, K., Hong, J., Marinova, D., & Zhu, L. (2009). Evolution and Governance of the Biotechnology and Pharmaceutical Industry of China. Mathematics and Computers in Simulation, 79, 2947–2956.CrossRef
29.
Nolan, P., & Yeung, G. (2001). Big business with Chinese characteristics: Two paths to growth of The firm in China under reform. Cambridge Journal of Economics, 25, 443–465.CrossRef
30.
Boutellier, R., & Ullman, F. (2007). China's unique position in discovery and preclinical research. Drug Discovery Today, 12, 4–7.CrossRef
31.
Ghauri, P. N., & Rao, P. M. (2009). Intellectual property, pharmaceutical MNEs and the developing world. Journal of World Business, 44, 206–215.CrossRef
32.
Lawrence, R. (2005). New opportunities in Asia: a focus on India and China. Drug Discovery Today, 10, 89–91.CrossRef
33.
Singh, R. (2006). Clinical research in China and India: a paradigm shift in drug development. Drug Discovery Today, 11, 675–676.CrossRef
34.
Lee, P. (2008). Opening the door to the Chinese pharmaceutical market. Chemistry Today, 26, 76–81.
35.
Gassmann, O., Reepmeyer, G., & Zedtwitz, M. V. (2008). Leading pharmaceutical innovation: Trends and drivers for growth in the pharmaceutical industry. Berlin: Springer.CrossRef
36.
Chan, L., Daim, T., Kocaoglu, D. (2015). A decision model for improving pharmaceutical innovation policy in China. Submitted to IEEE Transactions on Engineering Management.
37.
Kim, L. (1997). Imitation to innovation: The dynamics of korea's technological learning. Cambridge, MA: Harvard Business School Press.
38.
IMS. (2011). Shaping the biosimilars opportunity: A global perspective on the evolving biosimilars landscape. IMS Health.
39.
Frew, S. E., Sammut, S. M., Shore, A. F., Ramjist, J. K., Al-Bader, S., Rezaie, R., Daar, A. S., & Singer, P. A. (2008). Chinese health biotech and the billion-patient market. Nature Biotechnology, 26, 37–53.CrossRef
40.
Chiesa, V., & Chiaroni, D. (2005). Industrial clusters in biotechnology: Driving forces, development processes and management practices. London: Imperial College Press.
41.
Liu, X., & Buck, T. (2007). Innovation performance and channels for international technology spillovers: Evidence from Chinese high-tech industries. Research Policy, 36, 355–366.CrossRef
42.
Fan, E. X. (2003). Technological spillovers from foreign direct investment. Asian Development Review, 20, 34–56.
Metadata
Title
National Technology Planning: A Case Study on the Biopharmaceutical Industry in China
Authors
Leong Chan
Tugrul U. Daim
Dundar F. Kocaoglu
Copyright Year
2016
Book
Hierarchical Decision Modeling

Print ISBN: 978-3-319-18557-6

Electronic ISBN: 978-3-319-18558-3

Copyright Year: 2016

DOI
https://doi.org/10.1007/978-3-319-18558-3_9